Outcome of Board Meeting held on today i.e. September 05, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Dr Lalchandani Labs Ltd met on September 5, 2025 and approved several items. First, it cleared the 08th Annual Report along with the notice for the 08th Annual General Meeting scheduled for September 30, 2025 in New Delhi. Second, it appointed Mr. Mohan Lal Gandhi, a medical professional with prior board experience, as Non-Executive Independent Director for a 5-year term ending September 4, 2030. Third, it approved raising the authorised share capital from Rs. 4.5 crore to Rs. 11 crore, an increase of Rs. 6.5 crore, subject to shareholder approval. Finally, it appointed M/s. Chauhan Pradeep & Associates as Secretarial Auditors for five years (FY 2025-26 to FY 2029-30) and also as scrutinizer for the 08th AGM.
The near-2.5x jump in authorised capital suggests the company is positioning for a possible future fundraising or stock split, though no specific issue is announced yet. The new independent director strengthens board composition, while the other items are routine governance steps ahead of the AGM. No immediate material impact on shareholders.